180 related articles for article (PubMed ID: 33231855)
1. Generation of A Stable GFP-reporter Zika Virus System for High-throughput Screening of Zika Virus Inhibitors.
Zhang JW; Wang H; Liu J; Ma L; Hua RH; Bu ZG
Virol Sin; 2021 Jun; 36(3):476-489. PubMed ID: 33231855
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
Loe MWC; Lee RCH; Chu JJH
Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333
[TBL] [Abstract][Full Text] [Related]
3. Identification of Inhibitors of ZIKV Replication.
Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
Adcock RS; Chu YK; Golden JE; Chung DH
Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
[TBL] [Abstract][Full Text] [Related]
5. Harringtonine Inhibits Zika Virus Infection through Multiple Mechanisms.
Lai ZZ; Ho YJ; Lu JW
Molecules; 2020 Sep; 25(18):. PubMed ID: 32906689
[TBL] [Abstract][Full Text] [Related]
6. Identification of Ascomycin against Zika virus infection through screening of natural product library.
Zhou L; Zhou J; Chen T; Chi X; Liu X; Pan S; Chen W; Wu T; Lin T; Zhang X; Li YP; Yang W
Antiviral Res; 2021 Dec; 196():105210. PubMed ID: 34801589
[TBL] [Abstract][Full Text] [Related]
7. The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking
Riva L; Goellner S; Biering SB; Huang CT; Rubanov AN; Haselmann U; Warnes CM; De Jesus PD; Martin-Sancho L; Terskikh AV; Harris E; Pinkerton AB; Bartenschlager R; Chanda SK
J Virol; 2021 Oct; 95(22):e0099621. PubMed ID: 34468177
[TBL] [Abstract][Full Text] [Related]
8. Development of a replicon cell line-based high throughput antiviral assay for screening inhibitors of Zika virus.
Li JQ; Deng CL; Gu D; Li X; Shi L; He J; Zhang QY; Zhang B; Ye HQ
Antiviral Res; 2018 Feb; 150():148-154. PubMed ID: 29288699
[TBL] [Abstract][Full Text] [Related]
9. A platform of assays for the discovery of anti-Zika small-molecules with activity in a 3D-bioprinted outer-blood-retina model.
Dorjsuren D; Eastman RT; Song MJ; Yasgar A; Chen Y; Bharti K; Zakharov AV; Jadhav A; Ferrer M; Shi PY; Simeonov A
PLoS One; 2022; 17(1):e0261821. PubMed ID: 35041689
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Zika Virus Infection and Replication in Endothelial Cells and Astrocytes by PKA Inhibitor PKI 14-22.
Cheng F; Ramos da Silva S; Huang IC; Jung JU; Gao SJ
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212931
[TBL] [Abstract][Full Text] [Related]
11. Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus Inhibitors.
Gao Y; Tai W; Wang N; Li X; Jiang S; Debnath AK; Du L; Chen S
Viruses; 2019 Nov; 11(11):. PubMed ID: 31684080
[TBL] [Abstract][Full Text] [Related]
12. Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models.
Kim JA; Seong RK; Kumar M; Shin OS
Viruses; 2018 Feb; 10(2):. PubMed ID: 29425176
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Screening Identifies Mixed-Lineage Kinase 3 as a Key Host Regulatory Factor in Zika Virus Infection.
Xu H; Cheng M; Chi X; Liu X; Zhou J; Lin T; Yang W
J Virol; 2019 Sep; 93(18):. PubMed ID: 31270223
[TBL] [Abstract][Full Text] [Related]
14. Indole alkaloids inhibit zika and chikungunya virus infection in different cell lines.
Monsalve-Escudero LM; Loaiza-Cano V; Pájaro-González Y; Oliveros-Díaz AF; Diaz-Castillo F; Quiñones W; Robledo S; Martinez-Gutierrez M
BMC Complement Med Ther; 2021 Aug; 21(1):216. PubMed ID: 34454481
[TBL] [Abstract][Full Text] [Related]
15. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
[TBL] [Abstract][Full Text] [Related]
16. Using recombination-dependent lethal mutations to stabilize reporter flaviviruses for rapid serodiagnosis and drug discovery.
Baker C; Xie X; Zou J; Muruato A; Fink K; Shi PY
EBioMedicine; 2020 Jul; 57():102838. PubMed ID: 32574959
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel 2'-methyl-2'-fluoro-6-methyl-7-alkynyl-7-deazapurine nucleoside analogs as anti-Zika virus agents.
Yao G; Yu J; Lin C; Zhu Y; Duan A; Li M; Yuan J; Zhang J
Eur J Med Chem; 2022 Apr; 234():114275. PubMed ID: 35306290
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol affects Zika virus replication in vitro.
Mohd A; Zainal N; Tan KK; AbuBakar S
Sci Rep; 2019 Oct; 9(1):14336. PubMed ID: 31586088
[TBL] [Abstract][Full Text] [Related]
19. Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis.
Carbaugh DL; Baric RS; Lazear HM
J Virol; 2019 Jun; 93(12):. PubMed ID: 30944176
[TBL] [Abstract][Full Text] [Related]
20. Discovery of an imidazonaphthyridine and a riminophenazine as potent anti-Zika virus agents through a replicon-based high-throughput screening.
Fernandes RS; de Godoy AS; Santos IA; Noske GD; de Oliveira KIZ; Gawriljuk VO; Gomes Jardim AC; Oliva G
Virus Res; 2021 Jul; 299():198388. PubMed ID: 33887282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
